Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Adenoviral vector containing human p53 gene

EU orphan designation number: EU/3/06/404   
Active ingredient: Adenoviral vector containing human p53 gene
Indication: Treatment of Li Fraumeni Syndrome
Sponsor: Gendux Molecular Limited
70 Sir John Rogerson's Quay, Dublin 2, Ireland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
25/10/2006 Centralised Orphan - Designation EMEA/OD/034/06 (2006)5153 of 23/10/2006
13/12/2007 Centralised Orphan - Transfer of orphan designation EMEA/OD/034/06/T/01 (2007)6416 of 11/12/2007
05/03/2008 Other procedure EMEA/OD/034/06